The FDA has granted Fast Track designation to BM-3103, a novel topical mTOR inhibitor for epidermolysis bullosa simplex currently in phase 2.
As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...
ROOTSTOWN, Ohio--(BUSINESS WIRE)--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, ...
BioMendics, LLC, a clinical-stage biotechnology company developing innovative therapies for rare genetic skin disorders, ...
Most children can't wait to play outside in the sunny summer days. But little Blake Kenyon longs for winter - because of a rare health condition that causes his skin to blister in the heat. The ...
The patient has the Hallopeau-Siemens variant of dystrophic epidermolysis bullosa (EB). EB comprises a group of rare genetic states that are characterized by extremely fragile skin and recurrent ...
The four main types of epidermolysis bullosa (EB): dystrophic epidermolysis bullosa (DEB), epidermolysis bullosa simplex (EBS), junctional epidermolysis bullosa (JEB) and Kindler syndrome (KS) are ...
Dermatology Nursing. 2005;17(1):56-59. The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures.
In the present study, we analyzed a large, non-consanguineous five-generation family residing in Gujarat, India (Figure 1d). Blood samples were obtained, after informed consent, from a total of 14 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with epidermolysis bullosa simplex treated with ...
ROOTSTOWN, Ohio--(BUSINESS WIRE)--As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results